Market Overview

According to Fortune Business Insights, the global ultrasound needle guides market size was valued at USD 391.7 million in 2025. The market is projected to grow from USD 416.1 million in 2026 to USD 620.6 million by 2034, exhibiting a CAGR of 5.1% during the forecast period. North America dominated the ultrasound needle guides market with a market share of 32.78% in 2025.

Fortune Business Insights™ has deep-dived into these insights in its latest research report, titled “Ultrasound Needle Guides Market, 2026-2034.”

The analysis shows that the market growth is heavily influenced by an increasing shift toward minimally invasive and ultrasound-guided procedures, such as biopsies and fluid aspirations, which shorten procedure times, improve needle visualization, and reduce complications. For example, according to data from the National Center for Biotechnology Information (NCBI) in October 2025, a study at University Hospital Würzburg in Germany reported that out of 250 biopsies performed, 118 (47.2%) utilized ultrasound guidance. This trend indicates a strong demand for ultrasound needle guides worldwide.

Major Players Profiled in the Market Report:

• CIVCO Medical Solutions (U.S.)
• GE Healthcare (U.S.)
• FUJIFILM Sonosite, Inc. (U.S.)
• Sheathing Technologies, Inc. (U.S.)
• Aspen Surgical (U.S.)
• Argon Medical Devices (U.S.)
• GEOTEK (U.S.)
• Mermaid Medical (Denmark)

Segments

Elimination of Reprocessing and Reduced Cross-Contamination to Propel Disposable Segment Growth

Based on type, the market is divided into reusable and disposable. The disposable segment holds the largest market share and dominates the market owing to its significant comparative advantages, such as eliminating reprocessing steps, reducing cross-contamination risks, and simplifying logistics for interventional radiology suites and day-care centers. Meanwhile, the reusable segment is projected to grow at a CAGR of 4.5% during the forecast period.

Increasing Number of Prostate Biopsies to Drive Biopsy Segment Expansion

By application, the market is categorized into biopsy, regional anesthesia, vascular access, nerve block, fluid aspiration, and others. The biopsy segment is leading the market—projected to account for a 31.6% market share in 2026—as there is a high demand driven by the shift from CT-guided to ultrasound-guided procedures and the rising number of prostate biopsies globally (with UCLA Health reporting nearly 1 million prostate biopsies performed annually in the U.S.). Additionally, the vascular access segment is projected to grow at a rapid CAGR of 5.4%.

Hospitals & ASCs to Dominate the Market Due to High Procedure Volumes and Reimbursement Partnerships

Based on end-user, the market is segmented into hospitals & ASCs, clinics, diagnostic imaging centers, and others. The hospitals & ASCs segment holds the largest market share (projected to hold 69.2% in 2026) owing to the higher volume of ultrasound-guided procedures performed in these settings, better care accessibility, and favorable partnerships with reimbursement providers. The clinics segment is projected to grow at a CAGR of 5.1% during the forecast period.